Hyve Solutions Corporation, a wholly owned subsidiary of TD SYNNEX Corporation (NYSE:SNX) and a leading provider of hyperscale digital infrastructures, today announced the integration of Intel® Xeon® 6 processors into Hyve-designed motherboards and systems. This collaboration with Intel marks a significant step forward in meeting the diverse performance and efficiency requirements of modern computing environments, from high-performance AI applications to exceptional efficiency and cloud scalability.
Immunovant Announces IMVT-1402, A Next Generation Anti-FcRn; Plan To Submit IND And Initiate Phase 1 Study In Early 2023 With Initial Data Expected In Mid-2023.
In animal studies, deep IgG lowering similar to batoclimab with no or minimal impact on albumin and low-density lipoprotein (LDL) was observed.
Plan to submit IND and initiate Phase 1 study in early 2023
